An opportunity to finish the worldwide HIV epidemic: low-cost preventative drug to roll out on 2027

Generic variations of a groundbreaking injectable HIV-prevention drug needs to be out there for $40 a 12 months in additional than 100 nations from 2027, in accordance with Unitaid and the Gates Basis. The 2 organisations have entered into separate agreements with Indian pharmaceutical firms to provide cheaper generic variations of lenacapavir — a twice-yearly injection proven to scale back the danger of HIV transmission by greater than 99.9 % — for low- and middle-income nations. Particulars by Unitaid government directorn Philippe Duneton.



Source link